Novo Nordisk has launched a once-weekly insulin called Awiqli in India, which is reportedly the world's first such treatment. The launch is expected to provide wider access and competitive pricing for diabetes treatment in the country. The introduction of Awiqli in India may potentially change the way diabetes is treated, although details of its impact and pricing are not fully specified.